Zhe‐Sheng Chen

Research interests

Publications

• Gold nanoparticles and gold nanorods in the landscape of cancer therapy

  Molecular Cancer · 2023 · 10.1186/s12943-023-01798-8

• Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer

  Molecular Cancer · 2023 · https://doi.org/10.1186/s12943-023-01805-y

• Antimicrobial peptides for combating drug-resistant bacterial infections

  Drug Resistance Updates · 2023 · 10.1016/j.drup.2023.100954

• Advancements in nanoparticle-based treatment approaches for skin cancer therapy

  Molecular Cancer · 2023 · 10.1186/s12943-022-01708-4

• Understanding and targeting resistance mechanisms in cancer

  MedComm · 2023 · 10.1002/mco2.265

• Signaling pathways and therapeutic interventions in gastric cancer

  Signal Transduction and Targeted Therapy · 2022 · 10.1038/s41392-022-01190-w

• Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma

  Journal of Experimental & Clinical Cancer Research · 2022 · https://doi.org/10.1186/s13046-021-02208-x

• Microbiota in health and diseases

  Signal Transduction and Targeted Therapy · 2022 · https://doi.org/10.1038/s41392-022-00974-4

• m6A modification: recent advances, anticancer targeted drug discovery and beyond

  Molecular Cancer · 2022 · 10.1186/s12943-022-01510-2

• Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens

  Frontiers in Pharmacology · 2021 · https://doi.org/10.3389/fphar.2021.720726

• Therapeutic strategies to overcome taxane resistance in cancer

  Drug Resistance Updates · 2021 · https://doi.org/10.1016/j.drup.2021.100754

• Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification

  Drug Resistance Updates · 2020 · https://doi.org/10.1016/j.drup.2020.100720

• Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance

  Drug Resistance Updates · 2019 · 10.1016/j.drup.2019.100663

• Modulating ROS to overcome multidrug resistance in cancer

  Drug Resistance Updates · 2018 · 10.1016/j.drup.2018.11.001

• Autophagy and multidrug resistance in cancer

  癌症：英文版 · 2017 · https://doi.org/10.1186/s40880-017-0219-2

• The development of anticancer ruthenium( ii ) complexes: from single molecule compounds to nanomaterials

  Chemical Society Reviews · 2017 · https://doi.org/10.1039/c7cs00195a

• Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies

  Drug Resistance Updates · 2016 · 10.1016/j.drup.2016.05.001

• The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade

  Drug Resistance Updates · 2014 · https://doi.org/10.1016/j.drup.2014.11.002

• Silver nanoparticles: synthesis, properties, and therapeutic applications

  Drug Discovery Today · 2014 · https://doi.org/10.1016/j.drudis.2014.11.014

• Multidrug resistance associated proteins in multidrug resistance

  癌症：英文版 · 2011 · 10.5732/cjc.011.10329

• Biosynthesis of Nanoparticles by Microorganisms and Their Applications

  Journal of Nanomaterials · 2011 · 10.1155/2011/270974

• BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review

  Leukemia Research · 2010 · 10.1016/j.leukres.2010.04.016

• Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters

  Cancer Research · 2010 · 10.1158/0008-5472.can-10-0111

• Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2

  Cancer Research · 2008 · 10.1158/0008-5472.can-08-0499

• Erlotinib (Tarceva, OSI-774) Antagonizes ATP-Binding Cassette Subfamily B Member 1 and ATP-Binding Cassette Subfamily G Member 2–Mediated Drug Resistance

  Cancer Research · 2007 · 10.1158/0008-5472.can-07-2686

• Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.

  PubMed · 2003

• Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system.

  PubMed · 2002

• Transport of Cyclic Nucleotides and Estradiol 17-β-d-Glucuronide by Multidrug Resistance Protein 4

  Journal of Biological Chemistry · 2001 · 10.1074/jbc.m104833200

• Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.

  PubMed · 2000

Current projects

No projects listed.